Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →
JW

JOEL WHITE

MONUMENT ADVOCACY · Washington, DC
Registered · LDAActive

At a glance

Works on
Professional highlights appear here once this profile is claimed. Claim it →

Background

Career
Washington, DC · current
Government experience
Staff Director
Ways & Means Health Subcommittee; L.A. for Rep. Jim Greenwood; L.A. for Rep. Chris Shays
Covered official positions, as disclosed on federal filings

The past 12 months

Clients
9
past 12 months
Filings
17
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATEHealth & Human Services, Dept of (HHS)Centers For Medicare and Medicaid Services (CMS)Office of Management & Budget (OMB)White House Office

Specific issues

Issues related to insurance agent and broker fees in Medicare.
Medicare/Medicaid · 2026 Q1
Appropriations for CDC funding for patient education and outreach; EPIC Act; report on total cost of schizophrenia; access to treatment; issues related to serious mental illness; IMD exclusion; coordinated care, housing policy, and caregiver support; Road to Housing bill
Health Issues · 2026 Q1
Implementation of one big beautiful bill; Medicare quality programs (hospitals, doctors, Medicare Advantage); Medicaid quality programs and STARS ratings; Medicaid enrollment simplification and improvement.
Health Issues · 2026 Q1
Medicare Part D, Medicare Part B Issues, Importation of Drugs; H.R. 1, the One Big Beautiful Bill Act; H.R. 1492, S. 832, the EPIC Act; Medicare IRA implementation, Drug Premium Stabilization Program. Drug pricing, reimbursement and coverage related to MFN including CMMI models, 340B, IRA maximum fair price, ASP. PBM Reform included in H.R. 7194, the Consolidated Appropriations Act, the Department of Labor proposed PBM rule. Affordability and patient access issues.
Health Issues · 2026 Q1
Issues around electronic healthcare standards and interoperability, funding for standards development and integration, technology-based patient safety solutions.
Health Issues · 2026 Q1
Issues around interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency, 2026 rule and drug reimbursement changes.
Health Issues · 2026 Q1

Clients

2026 · 2 filings
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 2 filings
$██,███ / qtrFree in beta
2026 · 2 filings
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 2 filings
$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings14
2026 Q1
COUNCIL FOR AFFORDABLE HEALTH COVERAGE
Q1lda.gov →
2026 Q1
SOLVENTUM HEALTH INFORMATION SYSTEMS, INC.
Q1lda.gov →
2026 Q1
NATIONAL COUNCIL FOR PRESCRIPTION DRUG PROGRAMS
Q1lda.gov →
2026 Q1
INTEGRITY MARKETING GROUP
Q1lda.gov →
2026 Q1
CENCORA
Q1lda.gov →
2026 Q1
MCKESSON CORPORATION
Q1lda.gov →
2026 Q1
PHRMA
Q1lda.gov →
2026 Q1
ATHENAHEALTH, INC.
Q1lda.gov →
2026 Q1
SCHIZOPHRENIA POLICY ACTON NETWORK, INC.
Q1lda.gov →
2026 Q1
MCKESSON CORPORATION
RRlda.gov →
2026 Q1
INTEGRITY MARKETING GROUP
RRlda.gov →
2026 Q1
CENCORA
RRlda.gov →
2026 Q1
ATHENAHEALTH, INC.
RRlda.gov →
2026 Q1
SOLVENTUM HEALTH INFORMATION SYSTEMS, INC.
RRlda.gov →